Granules India Posts 60% YoY Growth in PAT as Revenue Climbs 22% in Q1FY27
Granules India Ltd., a vertically integrated pharmaceutical company, has announced its financial results for the quarter ended June 30, 2026. The company reported significant growth across key metrics, including Revenue from Operations and Profit After Tax (PAT).The unaudited results reflect strong operational performance. Revenue from Operations stood at INR 14,768 Mn, marking a 22% increase year over year (YoY). EBITDA reached INR 3,389 Mn, up 37% YoY. Profit Before Tax (PBT) before Exceptional Item was reported at INR 2,404 Mn, reflecting a 41% rise compared to the previous year. Consequently, PAT hit INR 1,800 Mn, showing a substantial growth of 60% YoY.
The company maintains a diversified portfolio across multiple product segments. For Q1FY27, Finished Dosages (FD), Active Pharmaceutical Ingredients (API), Pharmaceutical Formulation Intermediates (PFI), and Peptides CDMO contributed 74%, 13%, 9%, and 4% of the revenue from operations, respectively.
Quarterly Financial Summary
A detailed look at Granules India's quarterly performance is presented below:| Metric | Q1FY27 | Q4FY26 | Growth (QoQ) | Q1FY26 | Growth (YoY) |
|---|---|---|---|---|---|
| Revenue from Operations (INR Mn) | 14,768 | 14,706 | 0% | 12,101 | 22% |
| EBITDA (INR Mn) | 3,389 | 3,521 | -4% | 2,467 | 37% |
| EBITDA % | 23% | 24% | 20% | ||
| PBT Before Exceptional Item (INR Mn) | 2,404 | 2,464 | -2% | 1,704 | 41% |
| Exceptional Item / (Income) (INR Mn) | 0 | (159) | 259 | ||
| PAT (INR Mn) | 1,800 | 2,016 | -11% | 1,126 | 60% |
| PAT % | 12% | 14% | 9% |
Operational Health and Market Presence
In addition to the strong profitability metrics, the company reported that Return on Capital Employed (ROCE) improved to 18.0% in Q1FY27, up from 17.6% in FY26. The consolidated net debt stood at INR 1,012 Mn, representing a reduction of INR 8,467 Mn from Q1FY26. The Net Debt to EBITDA ratio was reported at 0.07x.Regarding geographic revenue distribution, the share from North America accounted for 72% in Q1FY27, down from 77% in Q1FY26. The contribution from Europe stood at 16% in Q1FY27, an increase from 13% in Q1FY26.
Management Commentary
Dr. Krishna Prasad Chigurupati, Chairman and Managing Director of Granules India Limited, commented on the results. He stated that the foundations strengthened during FY26 are now translating into greater execution confidence, strategic clarity, and business resilience.He emphasized that the company's focus remains centered on regulatory excellence and quality, portfolio transformation toward complex and differentiated products, geographic diversification, and scaling new growth engines. While acknowledging external cost pressures and supply chain volatility requiring continuous management in the coming quarters, he added that Granules is investing in R&D focused on Complex Gx, digitalization, operational excellence, sustainability, and talent to ensure long-term value creation for all stakeholders.
GRANULES Stock Price Movement
Shares of Granules India Limited are climbing as of 12:45 PM, gaining ₹8.75 or 1.00% in live trading, with the stock currently measured at ₹884.85. The company continues its strong rally near its annual peak after a volatile session, seeing trades reach high of ₹904.5 against an intraday low of ₹876.2.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.